Factors | COR | P-value | 95% CI for COR | AOR | P-value | 95% CI for AOR | ||
---|---|---|---|---|---|---|---|---|
Lower | Upper | Lower | Upper | |||||
Age group | ||||||||
< = 20 (ref) | ||||||||
21–40 | 0.48 | <0.001 | 0.35 | 0.67 | 0.48 | 0.011 | 0.27 | 0.84 |
41–60 | 0.32 | <0.001 | 0.23 | 0.45 | 0.36 | 0.001 | 0.20 | 0.64 |
61+ | 0.29 | <0.001 | 0.16 | 0.50 | 0.25 | 0.002 | 0.10 | 0.59 |
Sex | ||||||||
Male...Ref | ||||||||
Female | 0.99 | 0.89 | 0.79 | 1.22 | 0.16 | 0.53 | 1.11 | |
Sample | ||||||||
DBS...Ref | ||||||||
Frozen Plasma | 0.82 | 0.21 | 0.61 | 1.11 | omitted from the final model | |||
Testing lab | ||||||||
KEMRI NAIROBI…Ref | omitted from the final model | |||||||
AMPATH AND NHRL | 0.78 | 0.11 | 0.57 | 1.06 | ||||
ARV regimen | ||||||||
DF/3TC/EFV...Ref | ||||||||
TDF/3TC/NVP | 1.19 | 0.33 | 0.84 | 1.67 | 1.49 | 0.11 | 0.91 | 2.42 |
AZT/3TC/NVP | 0.76 | 0.09 | 0.55 | 1.05 | 0.76 | 0.23 | 0.49 | 1.19 |
Other | 0.85 | 0.43 | 0.58 | 1.26 | 0.82 | 0.47 | 0.49 | 1.39 |
Duration on ARVs | ||||||||
< 3 years…Ref | ||||||||
4–6 years | 1.24 | 0.09 | 0.97 | 1.59 | 1.31 | 0.13 | 0.93 | 1.87 |
7–9 years | 1.01 | 0.52 | 0.72 | 1.42 | 0.86 | 0.53 | 0.54 | 1.37 |
Justification for viral load | ||||||||
Clinical……Ref | ||||||||
Immunological | 1.19 | 0.15 | 0.94 | 1.51 | 1.37 | 0.08 | 0.96 | 1.97 |
Other | 0.86 | 0.48 | 0.56 | 1.32 | 1.06 | 0.83 | 0.60 | 1.88 |